Current Funding
HEALEY ALS Platform Trial
2020-2030
MGH / Sean M Healey Center
Site PI
Access for All in ALS (ALL ALS)
2024-2029
NIH
Site PI
COMBAT-ALS
2021-2028
MediciNova
Co-I
A pilot clinical trial of the novel antisense oligonucleotide nL-CHCHD-001 in CHCHD10-associated amyotrophic lateral sclerosis (CHCHD10-ALS)
2027-2028
Columbia University / DOD
Site PI
Sensory Function and Chronic Pain in Cerebral Palsy
2021-2027
NICHD
Co-PI
Clinic-Based Multi-Site ALS Natural History & Biofluid Study
2022-2027
FDA
Site PI
Multicenter longitudinal imaging in ALS for disease biomarker development
2023-2027
Minnesota Office of Higher Education
Co-PI
Multimodal longitudinal imaging of brain and cervical cord as an ALS disease biomarker using microstructure statistics and morphometry
2023-2027
FDA
Co-PI
An Intermediate-Size Expanded Access Protocol for Amyotrophic Lateral Sclerosis with Pridopidine
2024-2027
MGH / NIH
Site PI
Intermediate-Size Expanded Access Trial of Autologous Hybrid TREG/Th2 Cell Therapy (RAPA-501) of Amyotrophic Lateral Sclerosis
2024-2027
MGH / NIH
Site PI
Nano-QuIC Testing for Early ALS Diagnosis
2025-2027
Never Surrender, Inc.
PI
Biorepository to Support ALS Research in Minnesota
2023-2026
MN Office of Higher Education - Tomassoni ALS Research Funds
PI
Identification of protective factors for spinal motor neurons using an iPSCs model
2023-2026
MN Office of Higher Education - Tomassoni ALS Research Funds
Co-PI
A Pilot Partnership to Expedite Enrollment in ALS Trials: Acceleration Center of Enrollment (ACEs) in ALS Trials in Minnesota
2024-2026
MGH / Sean M Healey Center
Site PI
Clinical Trial Readiness in Charcot-Marie-Tooth Disease
2024-2026
Charcot-Marie-Tooth Association
Site PI
Expanded Access Protocol Infrastructure Support Program
2024-2026
MGH / Sean M Healey Center
Site PI
